This is a Validated Antibody Database (VAD) review about rat eukaryotic elongation factor 2 kinase, based on 4 published articles (read how Labome selects the articles), using eukaryotic elongation factor 2 kinase antibody in all methods. It is aimed to help Labome visitors find the most suited eukaryotic elongation factor 2 kinase antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
eukaryotic elongation factor 2 kinase synonym: SMEF2K

Abcam
domestic rabbit monoclonal (EP881Y)
  • western blot; human; 1:1000; loading ...; fig s6a
Abcam eukaryotic elongation factor 2 kinase antibody (Abcam, ab45168) was used in western blot on human samples at 1:1000 (fig s6a). Theranostics (2020) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology eukaryotic elongation factor 2 kinase antibody (Cell Signaling, 3692) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology eukaryotic elongation factor 2 kinase antibody (CST, 3692) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology eukaryotic elongation factor 2 kinase antibody (Cell Signaling Technology, 3692) was used in western blot on human samples . Cell Syst (2017) ncbi
Articles Reviewed
  1. Chen X, Wang K, Guo W, Li L, Yu P, Sun X, et al. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics. 2020;10:1833-1848 pubmed publisher
  2. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  3. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  4. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher